Why the study?
Do miR-126-3p and miR-223-3p predict thrombotic risk in patients with acute myocardial infarction undergoing primary angioplasty?
Do miR-126-3p and miR-223-3p predict thrombotic risk in patients with acute myocardial infarction undergoing primary angioplasty?
miR-126-3p and miR-223-3p may serve as useful biomarkers for ischemic risk stratification after acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
miR-223-3p and miR-126-3p may support post-AMI thrombotic risk stratification; leaves open prospective validation before clinical adoption.
The miR-223-3p and the miR-126-3p are promising independent predictors of thrombotic events and can be used for ischemic risk stratification after AMI.
No takes yet. Share an insight, caveat, or question.
Hromádka et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: